A Phase IIb/III Clinical Study to Evaluate the Efficacy and Safety of APC101 in Patients With Postherpetic Neuralgia.
Clinical trial NCT07599800 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07599800
- Sponsor
- Andros Pharmaceuticals Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-01
- Primary completion
- 2028-12-31
- Enrollment
- 333
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.